Esperion Therapeutics Quote, Financials, Valuation and Earnings

Invest. Do Good. Get Rewarded. Just $0.25/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Buy

ESPR
Esperion Therapeutics

Last Price:

2.48

Seasonality Move:

33.73%

7 Day Trial

ALL ACCESS PASS

$ 7

Access The Stock Grader Trading Tool From "The King Of Quants"

More details here...

Esperion Therapeutics Price Quote

$2.48

+0.01 (+2.9%)

(Updated: November 22, 2024 at 2:41 AM ET)

Esperion Therapeutics Key Stats

Buy

Esperion Therapeutics (ESPR) is a Buy

Day range:

$2.35 - $2.51

52-week range:

$1.15 - $3.40

Dividend yield:

P/E ratio:

0.00

P/S ratio:

1.25

P/B ratio:

Volume:

3.1M

Avg. volume:

4.4M

1-year change:

107.56%

Market cap:

$423.6M

Revenue:

$116.3M

EPS:

$-0.64

How Much Does Esperion Therapeutics Make?

How Much Are Esperion Therapeutics's Sales Annually?
ESPR Revenues are $116.3M
How Much Profit Does Esperion Therapeutics's Make A Year?
ESPR net income is -$209.2M

Is Esperion Therapeutics Growing As A Company?

What Is Esperion Therapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.52%
What Is Esperion Therapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%

Esperion Therapeutics Stock Price Performance

Did Esperion Therapeutics Stock Go Up Last Month?
Esperion Therapeutics share price went up by 19.9% last month
Did ESPR's Share Price Rise Over The Last Year?
ESPR share price rose by 107.56% over the past 1 year

What Is Esperion Therapeutics 52-Week High & Low?

What Is Esperion Therapeutics’s 52-Week High Share Price?
Esperion Therapeutics has traded as high as $3.40 over the past 52 weeks
What Is Esperion Therapeutics’s 52-Week Low Share Price?
Esperion Therapeutics has traded as low as $1.15 over the past 52 weeks

Esperion Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Esperion Therapeutics?

How Much Debt Does Esperion Therapeutics Have?
Total long term debt quarterly is $262.9M
How Much Cash Does Esperion Therapeutics Have?
Cash and short term investments quarterly total is $144.7M
What Is Esperion Therapeutics’s Book Value Per Share?
Book value per share is -1.89

Is Esperion Therapeutics Cash Flow Positive?

What Is ESPR Cash Flow From Operations?
Cash flow from operations (TTM) is -$25.8M
What Is Esperion Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $56M
What Is Esperion Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$317K

Esperion Therapeutics Return On Invested Capital